Best Thyroid Cancer Doctors in Hyderabad — CION's Dedicated Thyroid Oncology Panel

The best doctor depends on your stage and type. For surgery, look for a surgical oncologist with onco-specific training and high annual thyroid surgery volume — not a general surgeon who occasionally operates on thyroids. For advanced or metastatic disease, look for a medical oncologist current with TKIs (lenvatinib, sorafenib, vandetanib for medullary). At CION, every thyroid cancer case is reviewed by a multidisciplinary tumour board, with surgery led by our head and neck surgical oncology team and radioactive iodine therapy coordinated with accredited nuclear medicine centres.

An endocrinologist plays an important diagnostic role — evaluating thyroid nodules, performing or guiding FNA biopsy, and managing thyroid hormone replacement long-term. But once thyroid cancer is confirmed, surgical treatment must be led by an onco-trained surgeon (surgical oncologist or head and neck surgeon with cancer-specific training), and advanced or metastatic disease must be managed by a medical oncologist. An endocrinologist alone cannot direct thyroid cancer surgical treatment.

The biggest surgical risk in thyroid surgery is injury to the recurrent laryngeal nerve, which controls your voice — injury causes hoarseness or weak voice, and rarely permanent voice change. The two factors that most reduce this risk are (1) high annual case volume in the surgical team (high-volume surgeons have meaningfully lower complication rates than low-volume ones) and (2) use of intraoperative neuromonitoring (IONM) to identify and protect the nerve during surgery. At CION, both standards are part of our thyroid surgery pathway — ask your surgeon directly about volume and IONM at your consultation.

It depends on the type, size, and stage of your cancer. For most differentiated thyroid cancers (papillary or follicular) that are larger than 1–2 cm, have spread to lymph nodes, or have extra-thyroidal extension, radioactive iodine (RAI) is given 4–6 weeks after surgery to destroy any remaining thyroid tissue and microscopic cancer. RAI is not given for very small low-risk cancers, medullary thyroid cancer, or anaplastic thyroid cancer (which do not take up iodine). The decision is made by the tumour board based on your specific case.

Radioactive iodine (I-131) is given as a capsule or liquid. Thyroid cells — including any remaining cancer cells — naturally absorb iodine, so the radioactive iodine specifically targets these cells and destroys them. You will be mildly radioactive for several days after treatment and will need to stay in an isolation room for 1–3 days (depending on dose), avoid close contact with pregnant women and young children for 1–2 weeks, and follow specific precautions. CION coordinates RAI therapy with accredited nuclear medicine centres in Hyderabad — full pathway support, including the post-RAI scan and follow-up.

Current guidelines have moved toward less extensive surgery for select low-risk thyroid cancers. For papillary thyroid cancer smaller than 4 cm, confined to one lobe, with no high-risk features and no lymph node involvement, lobectomy (removing only one lobe) may be sufficient and avoids lifelong thyroid hormone replacement. For larger tumours, multifocal disease, lymph node involvement, or aggressive subtypes, total thyroidectomy is required. The decision is made at the tumour board based on your imaging, biopsy, and clinical features.

Most thyroid cancers are not hereditary. However, medullary thyroid cancer (about 5% of thyroid cancers) is hereditary in approximately 25% of cases — caused by a RET gene mutation, often as part of Multiple Endocrine Neoplasia type 2 (MEN2) syndrome. If you have medullary thyroid cancer, genetic testing is mandatory — and if positive, your children, siblings, and parents need testing too. Some papillary thyroid cancers also cluster in families. CION offers genetic counselling and testing for hereditary thyroid cancer.

A second opinion is especially valuable for thyroid cancer — both because the question of how much surgery you need (lobectomy vs total thyroidectomy) varies meaningfully across centres, and because surgical volume and technique directly affect complications. At CION the second opinion is free, written, and yours to keep — our multidisciplinary tumour board reviews your imaging, FNA biopsy, and existing recommendation and provides a documented opinion you can take anywhere.

Costs vary by procedure. Lobectomy ranges approximately ₹1,00,000 to ₹2,00,000; total thyroidectomy ranges ₹1,50,000 to ₹3,00,000; central or lateral neck dissection adds to surgical cost; radioactive iodine therapy ranges ₹50,000 to ₹1,50,000 depending on dose and isolation requirements; targeted therapy for advanced disease is significantly higher per month. For a detailed cost breakdown by treatment type, see our thyroid cancer treatment in Hyderabad page. Every CION patient receives a written, itemised cost estimate before treatment begins. Aarogyasri, EMI, and cashless insurance are accepted.

Yes. When booking your consultation, request a specific doctor by name. We confirm availability and arrange the appointment. Your chosen doctor becomes your named lead specialist for the duration of your care, while other panel specialists join for their part of the journey through the tumour board.